The product information provided in this website is intended only for residents of the United States. Leadiant Biosciences is a research-based pharmaceutical company that dedicates considerable scientific and financial resources to the research, development, and distribution of novel and effective therapies for patients affected by rare disease.
At Leadiant Biosciences, our legacy of serving patients is as strong as the future we envision. You make a tremendously positive impact on Leadiant and the lives of people living with ultra-rare diseases. Through your leadership and actions, you contribute to a patient-centered culture that drives business performance.
We are passionate about putting the patient first and ensuring their voice, experience and insights are represented in everything we do. Hear from our patients about their journeys living with a rare disease. Discovering and developing a new drug is an expensive and challenging process that can take between 10 and 15 years from discovery to commercialization.
At Leadiant Biosciences, we understand that people living with rare diseases have needs that extend far beyond medicine, which is why we provide resources and educational materials to support patients and their families throughout their journeys. We are driven to provide excellence and innovation because we understand in many cases, patients have no other treatment options.
Our innovative research programs and development of novel product candidates are led by scientists in partnership with a wide range of physicians, researchers, and leading academic biotechnology organizations around the world.
Patients and caregivers play an increasingly important role in researching and developing new therapies for rare and ultra-rare diseases. We are passionate about putting the patient first and ensuring their voice, experience and insights are heard. This can include funding research through donations, participating in a clinical trial, contributing to a patient registry, working with regulatory decision makers, and sharing experiences to help companies and researchers better understand a disease.
Leadiant Biosciences is a research-based pharmaceutical company unlike any other. We are united by rare dedication and a unique culture where every employee contributes, and every patient matters. No menu assigned! Congratulations, Nancy! Latest News. Leadiant Biosciences, Inc.
Patient Stories We are passionate about putting the patient first and ensuring their voice, experience and insights are represented in everything we do.
Drug Development Process Discovering and developing a new drug is an expensive and challenging process that can take between 10 and 15 years from discovery to commercialization. Research and Development We are driven to provide excellence and innovation because we understand in many cases, patients have no other treatment options.
Role of Patients in Research and Drug Development Patients and caregivers play an increasingly important role in researching and developing new therapies for rare and ultra-rare diseases.For major operations, time is needed; time is needed for an organisation to be solid and strong right from the start. Alfasigma, an all-Italian pharmaceutical company, was founded on these assumptions: the outcome of the union between the Alfa Wassermann and Sigma-Tau groups - in operations since the middle of the last century - it immediately became one of the top five operators in the pharmaceutical sector in Italy, inheriting the high values and acknoledged expertise of these historic italian groups and putting the focus on the potential and on the specialisation.
Alfasigma is a highly competitive group, widely distributed across the nation but with a firm international outlook and furnished with the indispensable resources to fulfil its main tasks: research, development and innovation. A new adventure begun on the solid foundation of the past, forward-looking and facing future challenges with confidence, determination and, above all, great passion. The passion of knowing how to be transformed without ever losing sight of the identity and the objectives: the care and wellbeing of people and society.
Sigma-Tau Pharmaceuticals, Inc.
Pharmaceuticals with passion. News and Press Latest news Read more. Conferences Upcoming conferences Read more. Pharmacovigilance service Report side effects Read more. Offices and Plants Find our locations Read more.Find jobs Company reviews Find salaries. Upload your resume. Sign in. Review this company. Job Title.
Australia 28 reviews. Ratings by category. Sort by. Helpfulness Rating Date. English Any. Found 28 reviews matching the search. Good place to work. Only left because my wife got a job away from Sydney.
Was this review helpful? Yes No. Share Tweet. Copy link. Working at sigma is the best thing that happens. Working at sigma or accepting any role at sigma can jeopardize future success despite good money.
It has a bad internal culture. Lots of favouritism. People for other ethnicity moght feel isolated.Skip to Job PostingsSearch Close. Find jobs Company reviews Find salaries. Upload your resume. Sign in. Advanced Job Search. Salary Estimate. Job Type. Full-time Contract 40 Temporary 35 Part-time 7 Internship 2.
Experience Level. Upload your resume - Let employers find you. Page 1 of jobs. Displayed here are Job Ads that match your query. Indeed may be compensated by these employers, helping keep Indeed free for jobseekers.
Indeed ranks Job Ads based on a combination of employer bids and relevance, such as your search terms and other activity on Indeed. For more information, see the Indeed Terms of Service.
Welcome to Sigma
Pharmaceutical Quality Engineer. Aphena Pharma Solutions 2. The OE Principal for Diagnosis and Planning serves to look at the big picture of site performance and guide improvement activities across the enterprise.
Packaging Engineer Medical Devices contract. Regulatory Affairs Specialist. Familiarity with pharmaceutical regulatory affairs. Preparing, compiling, reviewing and processing the regulatory submissions documents including both pre….
Production Engineer. The Production Engineer will act as a technical resource for Operations personnel. They will apply technical skills to optimize plant operations, resolve plant…. Histology Laboratory Analyst. Allergan 3.COVID is upon us and, by all accounts, its impact will be felt for a while. As a pharmacist, you are at the forefront of assisting people with their healthcare. Today, Sigma Healthcare launches a new delivery platform to provide a more convenient home delivery pharmacy service, in partnership with nimble Australian logistics company Drive Yello.
This follows the decision. We have been incredibly saddened by the devastating loss of life, property and livelihood during the ongoing bushfire emergency. Bushfire relief and recovery is a complex issue and under. As bushfires continue to ravage our nation, our thoughts are with the individuals and communities who have been displaced or impacted. Thank you to all our brave firefighters, police, emergency. Sigma Healthcare is aware of a current scam campaign targeting job seekers via LinkedIn and directly.
Individuals posing as Sigma employees have approached job seekers to contact them via Google. Sigma Healthcare has today announced a new three-year agreement with Scrypt Ventures to license their Scrypt HQ digital pharmacy platform.
The Scrypt HQ platform is a digital solution that improves. Paul Sullivan, Group Manager of Sigma Financial Services, outlines the five fundamentals that can go wrong in a pharmacy business and how to diagnose the specific challenges you face — so you can.
Sigma welcomes the decision of Astra Zeneca to commit to distribute their medicines to community pharmacy through the national CSO wholesaler network. This month, we focus on stories calling for the continued improvement of our. Sigma Healthcare and its branded pharmacies have launched an innovative partnership with Doctors on Demand called InClinic. InClinic provides patients with an Australian first, timely access to.
The Vinnies Soup Vans provide daily meals and friendship for those. The winners will. The flu season is upon us — essential information for Sigma pharmacists.
Better prepared to provide better care and keep patients healthy. Sigma strongly rejects the allegations made this week regarding the safe handling of stock at our distribution centres.
Sigma Healthcare and its distribution centres adhere to all regulatory. The big winners of the night include.Sigma Pharmaceuticals turns a corner
Leading consumer healthcare brands Amcal and Guardian have announced two exciting new initiatives which are set to revolutionise the retail pharmacy landscape in During last. Who is Sigma? Sigma Healthcare is a leading Australian-based wholesale and distribution business.
We have the largest pharmacy network in Australia, with over 1, branded and independent stores. We know it can be challenging to stay on top of healthy habits over summer, especially when the calendar is full of holidays and time away from work.
With a Blackhawk helicopter of course! Leading pharmacy group Discount Drug Stores DDS has topped the national charts for customer satisfaction yet again, being named the best performing pharmacy for the fifth month in a row, and sixth. Amcal General Manager, Brian Tomlin, has praised Supercars driver and Amcal partner, Jack Perkins, in helping to destigmatise diabetes and encourage those with the condition to live without.Sigma Healthcare Limited is a full line wholesale and distribution business to pharmacy.
Guardian should not to be confused with the East Asian pharmacy Guardian. Sigma restructured indisposing of its generic drug manufacturing business.
The company's sales revenue grew 1. The DDS acquisition was set to add pharmacies under that brand to the Sigma network. InSigma shares were placed in a trading halt on the Australian Stock Exchange — initially due to a profit warning.
Since then, allegations of accounting irregularities  and preferential deals negotiated with certain pharmacy chains at the expense of smaller independent chemists that left Sigma losing money at the expense of their own Amcal and Guardian Pharmacies banners  and forsaking cashflow emerged. The events resulted in the initiation of a shareholder class action before the Federal Court of Australia.
From Wikipedia, the free encyclopedia. Redirected from Sigma Pharmaceuticals. This article is about the parent company of the Australian chain 'Guardian Pharmacies'. This article relies too much on references to primary sources. Please improve this by adding secondary or tertiary sources. December Learn how and when to remove this template message. Net income. Sydney Sun. Retrieved 8 September Retrieved 3 May The Age.
The Sydney Morning Herald.In Leadiant Biosciences has come under fire for creating a monopoly for CDCA and unnecessarily increasing the price by a factor of Construction began in of an industrial facility in Pomezia equipped with state-of-the-art automatic production machinery to provide steady employment for 64 people. The choice of Pomezia for its headquarters created one of the first industrialization and urban development initiatives in an area of Central-southern Italy that had previously been mainly devoted to agriculture.
With the creation and launch of the Rekord B12 vitamin complex in September — an antiasthenic medicine that soon spread within the field of restorative infantile therapies — Sigma-Tau definitively asserted itself as a pharmaceutical manufacturer in Italy and abroad.
From the s onwards, Sigma-Tau focused on experimenting with new medicines for rare diseases — a commitment that in would cause it to become the fourth largest pharmaceutical company in the world and assignee in the United States of an Orphan Drug Designation,  subsequently receiving another seven. With the discovery in the s of Carnitine deficiency syndromes. Qan illness with a fatal outcome, Sigma-Tau focused the investigative efforts of its laboratories on research into a molecule capable of opposing the disease.
This was to bring about the creation of L-carnitineone of the few Italian pharmaceutical products widely received outside Italy, and which was recognized by the United States in for its value as a life saving medicine. The chemical and biologic pharmacology study of carnitinea substance of natural origin, enabled greater understanding of its efficacy in correcting the biochemical and metabolic defects at the base of numerous other pathologies. Fondazione Sigma-Tau was created in as a charitable organization with the aim of developing research, promoting scientific and cultural progress and the safeguarding of the results of scientific investigation.
The Sigma-Tau Group achieved a corporate turnover of million euro inemploys a workforce of 1, and possesses a portfolio of more than products marketed in Italy and abroad, with regards to the following therapeutic areas: Cardiometabolic disorders, Orthopedic and Rheumatologic diseases, Broncho-Pneumology, Infectology, Oncology, Neurology, Gastroenterology, Dermatology, Urology and Gynecology, Malaria and Rare Diseases. The Group is a leader in the nutraceutics industry and produces supplements of high scientific interest.
Its product range also includes high-end dermocosmetics lines, as well as oral and personal care products. Since it has filed patents confirming itself, among the national Italian owned, as a major player in the registration of new molecules or important technological innovations.
With eight products for the treatment of rare and neglected diseases, today Sigma-Tau is a pharmaceutic player acting in the forefront in the treatment of Rare Diseases. The goal of its recently created Global Rare Disease Business Unit is to contribute to the progresses in the knowledge, diagnosis and treatment of Rare Diseases.
Sigma-Tau in collaboration with the non-profit organization Medicines for Malaria Venture MMV has developed a new medicine for the treatment of malaria a fixed combination consisting of dihydroartemisinin and piperaquinejudged to be one of the most effective antimalaria medicines available and the best combination containing artemisinin. The new drug has obtained the registration in Cambodia, Ghana and Tanzania and is started in Burkina Faso, Mozambique and other key African endemic countries.
Sigma-Tau is the main element of a group in which other companies operate, in accordance with the prospects of the corporate development plan.
Founded in and active both in the pharmaceutical market and that of consumer products sold in pharmacies. Avantgarde has developed its business within the dermatological, gynaecological and paediatric sectors; for consumer products the focus is geared to dermocosmetic sector and to oral hygiene with OTC products.
Incorporated in as part of the Sigma-Tau Group, Biosint is currently a world-leading producer of L-Carnitine derived by chemical synthesis. The company manufactures and distributes active pharmaceutical ingredients, lactic ferments and nutraceutical products obtained by chemical synthesis and fermentation. Its operations are carried out in full compliance with current good manufacturing practices cGMPat establishments approved by FDA and main domestic and international Regulatory Authorities.
Biofutura was founded in with the objective of developing pharmaceutical products in the cure of diseases of the central nervous system and respiratory system.
Activity also spread to the development and marketing of products derived from the carnitine biological system.
Responsible for the research and development of substances active on important areas of treatment including oncology and immunology and on diseases that are rare, neglected and with high social impact. A recently established research centre that co-ordinates research and development activity relating to selected products and provides clinical development and chemical analytical expertise. While the company claims to operate in absolute respect of ethical principles and existing legislation it received a tremendous amount of negative attention due their action to increase the price of an orphan drug to such extent it became impossible to pay for the drug.
In Sigma-Tau became equipped with a water conditioning plant. Sincethe commitment to reduce impact on the environment in the elimination of solvents in aid of water in many preparations has produced continuing reduction in CO2 emissions that have fallen from 5, tons to 5, in SinceSigma-Tau has begun waste sorting and choosing eco-compatible materials.
Over the years, Sigma-Tau has developed numerous partnershipsformed with associations and bodies engaged — at national and international level — in projects and activities with a social emphasis, with particular focus on the areas of health and social welfare.
The company also provides its medicines free-of-charge to around 40 national and international organizations operating in conflict and post-conflict contexts to support those people stricken by natural disasters and famine.
At international level, Sigma-Tau:. Sigma Scorpii and Tau Scorpii are the two stars that flank Antares at the centre of the Scorpius constellation. Arabs considered the red Antares the heart of the constellation and therefore regarded the bright stars positioned beside it — Sigma and Tau — as the arteries leading away from the heart, as indicated by the name for the two stars together, al-Niyat 'arteries'.
From Wikipedia, the free encyclopedia. Redirected from Sigma-Tau. This article contains content that is written like an advertisement.